Microbot Medical Inc.
MBOT
$2.41
$0.114.78%
NASDAQ
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 103.05% | 66.87% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 7.17% | 3.71% | |||
| Operating Income | -7.17% | -3.71% | |||
| Income Before Tax | 3.16% | -2.20% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 3.16% | -2.20% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 3.16% | -2.20% | |||
| EBIT | -7.17% | -3.71% | |||
| EBITDA | -7.19% | -3.77% | |||
| EPS Basic | 30.78% | 22.42% | |||
| Normalized Basic EPS | 30.75% | 22.50% | |||
| EPS Diluted | 30.78% | 22.42% | |||
| Normalized Diluted EPS | 30.75% | 22.50% | |||
| Average Basic Shares Outstanding | 39.94% | 31.81% | |||
| Average Diluted Shares Outstanding | 39.94% | 31.81% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||